	Omitting axillary dissection in breast cancer patients with one to two positive sentinel nodes undergoing mastectomy: a retrospective and prospective cohort study with a target trial emulation. Int J Surg Xie H, Wang X, Gu X, Wu C, Guo W, Li R, Qiu B, Zhang Z, Gao P, Meng X, Du L, Liu S, Gnant M, Chen J. PMID: 42682276 [PubMed]
	DNA Methylation Testing in Cervical Cancer: A Triage Tool for HPV-Based Screening and Post-Treatment Surveillance. J Obstet Gynaecol Res Xu Y, Zhou X, Guo L, Lyu R. PMID: 42681848 [PubMed - indexed for MEDLINE]
	CDK4/6 Inhibitors in the Management of Hormone Receptor-Positive (HR+)/Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Advanced Breast Cancer in Indonesia: Challenges, Opportunities, and Recommendations. Asia Pac J Clin Oncol Panigoro SS, Haryono SJ, Prihantono P, Hermansyah D, Anwar SL, Azhar Y, Kurniawan F, Adiputra PAT, Yarso KY, Wihandono A. PMID: 42681803 [PubMed - as supplied by publisher]
	Large Language Models for Non-Coding RNA Biomarker Discovery in Breast Cancer. Methods Mol Biol Loganathan T. PMID: 42681533 [PubMed - indexed for MEDLINE]
	The association between uncertainty in illness and fear of cancer recurrence or progression in breast cancer patients: the parallel mediating roles of coping styles and the moderating role of perceived social support. Support Care Cancer Li M, Yuan J, Guo H, Wang S. PMID: 42681264 [PubMed - indexed for MEDLINE]
	Atezolizumab in early triple-negative breast cancer: the randomized phase 3 NSABP B-59/GeparDouze trial. Nat Med Loibl S, Tang G, Nekljudova V, Rastogi P, Rachakonda S, Reinisch M, Acosta J, Schneeweiss A, Hilton C, Seiler S, Bhargava R, Karn T, Cortazar P, Moreno F, Andersen J, Christensen S, Klare P, Murali S, Morales S, Huober J, Boileau JF, Rodríguez-Lescure Á, Boudreau D, Polewski PJ, Teply-Szymanski J, Mouta J, Mamounas EP, Denkert C, Wolmark N, Geyer CE Jr. PMID: 42680950 [PubMed - as supplied by publisher]
	Effects of transcutaneous electrical acupoint stimulation versus acupressure on the trajectories of multidimensional adverse reactions to chemotherapy in breast cancer patients: a secondary analysis of a randomized controlled trial. Support Care Cancer Yuan J, Zhao X, Li H, Li B, Tian C, Chu J, Kayishaer T, Tao Z, Jiang H, Hu X, Zhu B, Yang Y. PMID: 42680887 [PubMed - indexed for MEDLINE]
	Small Extracellular Vesicle and Total Lipid Profiles Provide a Diagnostic Advantage Over CA-125 Across Ovarian Cancer Subtypes. J Extracell Vesicles Rani S, Guanzon D, Lai A, Scholz-Romero K, Perrin L, Lourie R, Joshi V, McCart Reed AE, Ferguson K, Handberg A, Möller A, Salomon C. PMID: 42680694 [PubMed - indexed for MEDLINE]
	Dexamethasone-associated hyperglycemia during chemotherapy in endometrial and ovarian cancer: a retrospective study. Int J Gynecol Cancer Spicer K, Sánchez MC, Levin G, Ribeiro R, Zeng X, Bernard L, Mandilaras V, Gilbert L, Leung SOA. PMID: 42680636 [PubMed - as supplied by publisher]
	Corrigendum to "SUROVA Study: Global Real-World Treatment Strategies And Mortality Risk Prediction In Advanced Ovarian Cancer" [International Journal of Gynecological Cancer 36 (2026) 102688]. Int J Gynecol Cancer Chiva L, Ordas P, Mishra J, Ayhan A, Lee YY, Bogani G, Sp S, Lomnytska M, Stukan M, Fruscio R, Chura BF, Salcedo-Hernandez RA, De Iaco P, Haidopoulos D, Svintsitskiy V, Jain V, Stanciu P, Rawert FL, Akdemir C, Abdallah R, Chacon E, Minguez JA, Gil-Moreno A, Kharchenko K, Mofrad MH, Gebauer G, Díaz-Feijoo B, Scibilia G, Klaric M, , Saadeh FA, Mueller MD, Saarelainen S, García ÁT, Fotopoulou C, Coronado P, Demirkiran F, Goffin F, Tsolakidis D, Gonzalez-Martin A, SUROVA Study Group. PMID: 42680634 [PubMed - as supplied by publisher]
	Biological features associated with poor response to neoadjuvant chemotherapy in high-grade serous ovarian carcinoma. Int J Gynecol Cancer Rajavuori A, Li Y, Isoviita VM, Afenteva D, Astrén J, Aakula M, Nguyen MTN, Santarelli M, Micoli G, Muranen TA, Joutsiniemi T, Schwikoski B, Virtanen A, Hautaniemi S, Oikkonen J, Hynninen J. PMID: 42680633 [PubMed - as supplied by publisher]
	The Effect of Exercise on Reproductive and Metabolic Outcomes in Women With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. J Obstet Gynaecol Res Zou K, Ping Y, Wei Q, Zhao X, Wang Y, Wu D, Chen L, Wang S, Feng X. PMID: 42679860 [PubMed - indexed for MEDLINE]
	Welfare losses from breast cancer among women in high-income regions, 1990-2050. Cancer Epidemiol Kong Y, Cui Y, Qiao S. PMID: 42679769 [PubMed - as supplied by publisher]
	Label- and- enzyme free electrochemical DNA biosensor for ultrasensitive detection of breast cancer prognostic marker ESR1. Bioelectrochemistry Khalil AA, Arafat W, El-Bab AF, Osman A, El-Moneim AA. PMID: 42679736 [PubMed - as supplied by publisher]
	Silver nanoparticles as breast cancer chemosensitizers: A systematic scoping review of speciation, combination efficacy, formulation, and safety. J Trace Elem Med Biol Alamri MA, Afzal M, Uniyal P, Afzal O, Akela MA, Phalak P. PMID: 42679702 [PubMed - as supplied by publisher]
	Corrigendum to 'Phase II study of trastuzumab-pkrb plus gedatolisib in patients with HER2-positive metastatic breast cancer who progressed after two or more HER2-directed therapies': [ESMO Open Volume 11, Issue 7, July 2026, 107706]. ESMO Open Kim JW, Park YH, Lee S, Ahn HK, Bae J, Park S, Chae H, Kim JH, Lee KH, Kim MH, Lee KE, Kang MJ, Park IH, Chae YS, Lee GW, Park KU, Lee EM, Park JH, Kim JE, Kim HJ, Kim TH, Oh SY, Ko S, Byun JH, Ha JY, Kwon JH, Lee S, Choi JY, Jung JY, Park KH. PMID: 42679537 [PubMed - as supplied by publisher]
	Breast cancer outcomes in low- and middle-income countries: Interactions of tumor biology, clinical care, and health-system capacity-A structured narrative review with an Indonesian case study. Cancer Treat Res Commun Prajoko YW, Muniroh M. PMID: 42679453 [PubMed - as supplied by publisher]
	LENS: A mammography-specific hybrid CNN-Transformer with lesion-aware evidence modeling. PLoS One Hoang DQ, Cao VK, Nguyen TN, Nguyen NS. PMID: 42678997 [PubMed - indexed for MEDLINE]
	Association of MDM2 rs2279744 and rs937282 polymorphisms with breast cancer susceptibility and circulating MDM2 and p53 levels in Bangladeshi women: A case-control study. PLoS One Chowdhury MH, Islam F, Khan AA, Siddique MA, Hasan NB, Samrat MI, Tanisha MH, Tasnim J, Mahjabin S, Islam MN, Haque MA. PMID: 42678985 [PubMed - indexed for MEDLINE]
	Integrated multi-omics analyses identify an RAS-SLC11A2-associated molecular framework linking iron metabolism with PCOS-related cardiometabolic risk. Clin Exp Hypertens Zhang S, Xu Y, Cao T, Wang K, Jia L, Li J. PMID: 42678751 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 334516

Page 1 of 16726



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy